Ezetimibe Completely Replaced LDL-Apheresis for the Treatment of Familial Hypercholesterolemia and Coronary Artery Disease after CABG—A Case Report ()
ABSTRACT
Intensive treatment of
hyperlipidemia is an important factor in the prevention of cardiovascular
disease. Among several therapies, statins are well recognized as playing a central role, although low density
lipoprotein bound cholesterol-apheresis can be used to treat very severe cases
of familial hypercholesterolemia. However, statins are not always effective on
their own and, recently, ezetimibe has emerged as a unique anti- hypercholesterolemic
drug that acts as a cholesterol transporter inhibitor; its role is only
partially understood. I experienced rare case that appeared to benefit from
ezetimibe therapy, and report them as they help increase our knowledge
of this novel drug.
Share and Cite:
Yokoyama, I. (2013) Ezetimibe Completely Replaced LDL-Apheresis for the Treatment of Familial Hypercholesterolemia and Coronary Artery Disease after CABG—A Case Report.
Journal of Biomedical Science and Engineering,
6, 232-235. doi:
10.4236/jbise.2013.62A028.
Cited by
No relevant information.